Fundraising Fox

Aptatek

6 employees on LinkedIn · 1 known investors

Aptatek BioSciences develops handheld, smartphone-based home monitoring tools for chronic disease patients, using a proprietary DNA aptamer assay to detect small-molecule biomarkers in real time. Its first product is an FDA Breakthrough Device-designated phenylketonuria (PKU) monitoring test that measures phenylalanine levels for at-home or point-of-care use.

BiotechDigital HealthMedical Devices

Founders & leadership

MS
Milan StojanovicCofounder, Medical/Scientific Advisor
TW
Tilla WorgallCofounder, Scientific Advisor

Investors · 1

Anzu PartnersBillerica

In the news

[Funding News] Aptatek BioSciences Secures Undisclosed Fundingstartuprise.io · Jun 2024IP Group — International investor in impactful innovation - Edison Groupedisongroup.com · Sep 2022Medical Device Manufacturer, Canterbury Scientific Limited, Completes Investment into Aptatek BioSciences, Inc. Developing Advanced In-Home Monitoring of Chronic Diseasediagnosticsworldnews.com · Apr 2022Aptatek BioSciences Closes $4M Seed Funding - FinSMEsfinsmes.com · Mar 2022In-home health monitoring company completes $4M in seed funding -njbiz.com · Mar 2022Aptatek BioSciences, Inc. Completes $4 Million Seed Funding Led by IP Group, Inc. to Develop Advanced In-Home Monitoring of Chronic Disease - BioSpacebiospace.com · Mar 2022

Frequently asked questions

What does Aptatek do?
Aptatek BioSciences develops handheld, smartphone-based home monitoring tools for chronic disease patients, using a proprietary DNA aptamer assay to detect small-molecule biomarkers in real time. Its first product is an FDA Breakthrough Device-designated phenylketonuria (PKU) monitoring test that measures phenylalanine levels for at-home or point-of-care use.
Who founded Aptatek?
Aptatek was founded by Milan Stojanovic, Tilla Worgall.
Who are Aptatek's investors?
Aptatek's investors include Anzu Partners.